Assessment on the binding characteristics of dasatinib, a tyrosine kinase inhibitor to calf thymus DNA: insights from multi-spectroscopic methodologies and molecular docking as well as DFT calculation

References

• Ahmad, A., & Ahmad, M. (2018). Deciphering the mechanism of interaction of edifenphos with calf thymus DNA. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 188, 244–251. doi:10.1016/j.saa.2017.07.014
   PubMed Web of Science ®Google Scholar
• Alam, M. F., Varshney, S., Khan, M. A., Laskar, A. A., & Younus, H. (2018). In vitro DNA binding studies of therapeutic and prophylactic drug citral. International Journal of Biological Macromolecules, 113, 300–308. doi:10.1016/j.ijbiomac.2018.02.098
   PubMed Web of Science ®Google Scholar
• Ataci, N., Ozcelik, E., & Arsu, N. (2018). Spectrophotometric study on binding of 2-thioxanthone acetic acid with ct-DNA. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 204, 281–285. doi:10.1016/j.saa.2018.06.001
   PubMed Web of Science ®Google Scholar
• Baltazar, C. J., Mun, R., Tajmir-Riahi, H. A., & Bariyanga, J. (2018). Spectroscopic studies on the interaction of mimosine with BSA and DNA. Journal of Molecular Structure, 1161, 273–278. doi:10.1016/j.molstruc.2018.01.039
   Web of Science ®Google Scholar
• Barone, G., Terenzi, A., Lauria, A., Almerico, A. M., Leal, J. M., Busto, N., & García, B. (2013). DNA-binding of nickel(II), copper(II) and zinc(II) complexes: Structure–affinity relationships. Coordination Chemistry Reviews, 257(19-20), 2848–2862. doi:10.1016/j.ccr.2013.02.023
   Web of Science ®Google Scholar
• Bellodi, C., Lidonnici, M. R., Hamilton, A., Helgason, G. V., Soliera, A. R., Ronchetti, M., … Calabretta, B. (2009). Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells. Journal of Clinical Investigation, 119(5), 1109–1123. doi:10.1172/JCI35660
   PubMed Web of Science ®Google Scholar
• Chen, K. Y., Zhou, K. L., Lou, Y. Y., & Shi, J. H. (2019). Exploring the binding interaction of calf thymus DNA with lapatinib, a tyrosine kinase inhibitor: Multi-spectroscopic techniques combined with molecular docking. Journal of Biomolecular Structure and Dynamics, 37(3), 576–583. doi:10.1080/07391102.2018.1433067
   PubMed Web of Science ®Google Scholar
• Doenecke, D. (1977). Ethidium bromide (EB) binding to nucleosomal DNA: Effects on DNA cleavage patterns. Experimental Cell Research, 109(2), 309–315. doi:10.1016/0014-4827(77)90010-6
   PubMed Web of Science ®Google Scholar
• Dogan-Topal, B., Bozal-Palabiyik, B., Ozkan, S. A., & Uslu, B. (2014). Investigation of anticancer drug lapatinib and its interaction with dsDNA by electrochemical and spectroscopic techniques. Sensors and Actuators B: Chemical, 194, 185–194. doi:10.1016/j.snb.2013.12.088
   Web of Science ®Google Scholar
• Duyvestyn, J. M., Taylor, S. J., Dagger, S. A., & Langdon, W. Y. (2016). Dasatinib promotes the activation of quiescent hematopoietic stem cells in mice. Experimental Hematology, 44(5), 410–421.e5. doi:10.1016/j.exphem.2016.02.008
   PubMed Web of Science ®Google Scholar
• FDA. (2017a). Clinical pharmacology review. Retrieved from https://www.fda.gov/downloads/drugs/developmentapprovalprocess/developmentresources/ucm605699.pdf
   Google Scholar
• FDA. (2017b). FDA approves dasatinib for pediatric patients with CML. Retrieved from https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm584725.htm
   Google Scholar
• Fukui, K. (1982). Role of Frontier orbitals in chemical reactions. Science, 218(4574), 747–754. doi:10.1126/science.218.4574.747
   PubMed Web of Science ®Google Scholar
• Gholivand, M. B., Kashanian, S., Peyman, H., & Roshanfekr, H. (2011). DNA-binding study of anthraquinone derivatives using chemometrics methods. European Journal of Medicinal Chemistry, 46(7), 2630–2638. doi:10.1016/j.ejmech.2011.03.034
   PubMed Web of Science ®Google Scholar
• Haq, I., Ladbury, J. E., Chowdhry, B. Z., Jenkins, T. C., & Chaires, J. B. (1997). Specific binding of hoechst 33258 to the d(CGCAAATTTGCG)2 duplex: Calorimetric and spectroscopic studies. Journal of Molecular Biology, 271(2), 244–257. doi:10.1006/jmbi.1997.1170
   PubMed Web of Science ®Google Scholar
• Hegde, A. H., & Seetharamappa, J. (2014). Fluorescence and circular dichroism studies on binding and conformational aspects of an anti-leukemic drug with DNA. Molecular Biology Reports, 41(1), 67–71. doi:10.1007/s11033-013-2838-2
   PubMed Web of Science ®Google Scholar
• Jamshidvand, A., Sahihi, M., Mirkhani, V., Moghadam, M., Mohammadpoor-Baltork, I., Tangestaninejad, S., … Gharaghani, S. (2018). Studies on DNA binding properties of new Schiff base ligands using spectroscopic, electrochemical and computational methods: Influence of substitutions on DNA-binding. Journal of Molecular Liquids, 253, 61–71. doi:10.1016/j.molliq.2018.01.029
   Web of Science ®Google Scholar
• Kantarjian, H., Shah, N. P., Hochhaus, A., Cortes, J., Shah, S., Ayala, M., … Baccarani, M. (2010). Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia. New England Journal of Medicine, 362(24), 2260–2270. doi:10.1056/NEJMoa1002315
   PubMed Web of Science ®Google Scholar
• Kashanian, S., Shahabadi, N., Roshanfekr, H., Shalmashi, K., & Omidfar, K. (2008). DNA binding studies of PdCl2(LL) (LL = chelating diamine ligand: N, N-dimethyl trimethylen diamine) complex. Biochemistry (Moscow)), 73(8), 929–936. doi:10.1134/S0006297908080117
   PubMedGoogle Scholar
• Krieger, M., Scott, M. P., Matsudaira, P. T., Lodish, H. F., Darnell, J. E., Zipursky, L., …, Berk, A. (2004). Molecular cell biology. New York, NY: W.H. Freeman and CO.
   Google Scholar
• Lebedeva, N. S., Yurina, E. S., Gubarev, Y. A., & Syrbu, S. A. (2018). Interactions of tetracationic porphyrins with DNA and their effects on DNA cleavage. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 199, 235–241. doi:10.1016/j.saa.2018.03.066
   PubMed Web of Science ®Google Scholar
• Nori, A., & Kopecek, J. (2005). Intracellular targeting of polymer-bound drugs for cancer chemotherapy. Advanced Drug Delivery Reviews, 57(4), 609–636. doi:10.1016/j.addr.2004.10.006
   PubMed Web of Science ®Google Scholar
• Olmsted, J., & Kearns, D. R. (1977). Mechanism of ethidium bromide fluorescence enhancement on binding to nucleic acids. Biochemistry, 16(16), 3647–3654. doi:10.1021/bi00635a022
   PubMed Web of Science ®Google Scholar
• Padmanabhan, J., Parthasarathi, R., Subramanian, V., & Chattaraj, P. K. (2006). Group philicity and electrophilicity as possible descriptors for modeling ecotoxicity applied to chlorophenols. Chemical Research in Toxicology, 19(3), 356–364. doi:10.1021/tx050322m
   PubMed Web of Science ®Google Scholar
• Quintas-Cardama1, A., & Cortes, J. (2009). Molecular biology of bcr-abl1-positive chronic myeloid leukemia. Blood, 19, 1619–1630. doi:10.1182/blood-2008-03-144790
   Google Scholar
• Rao, G., Kim, I., Conforti, F., Liu, J., Zhang, Y., & Giaccone, G. (2018). Dasatinib sensitises KRAS-mutant cancer cells to mitogen-activated protein kinase kinase inhibitor via inhibition of TAZ activity. European Journal of Cancer, 99, 37–48. doi:10.1016/j.ejca.2018.05.013
   PubMed Web of Science ®Google Scholar
• Rauf, S., Gooding, J. J., Akhtar, K., Ghauri, M. A., Rahman, M., Anwar, M. A., & Khalid, A. M. (2005). Electrochemica approach of anticancer drugs-DNA interaction. Journal of Pharmaceutical and Biomedical Analysis, 37(2), 205–217. doi:10.1016/j.jpba.2004.10.037
   PubMed Web of Science ®Google Scholar
• Ross, P. D., & Subramanian, S. (1981). Thermodynamics of protein association reactions: Forces contributing to stability. Biochemistry, 20(11), 3096–3102. doi:10.1021/bi00514a017
   PubMed Web of Science ®Google Scholar
• Saenger, W. (1984). Principles of nucleic acid structure. New York, NY: Springer-Verlag.
   Google Scholar
• Savage, D. G., Szydlo, R. M., & Goldman, J. M. (1997). Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year period. British Journal of Haematology, 96(1), 111–116. doi:10.1046/j.1365-2141.1997.d01-1982.x
   PubMed Web of Science ®Google Scholar
• Shi, J. H., Chen, J., Wang, J., & Zhu, Y. Y. (2015). Binding interaction between sorafenib and calf thymus DNA: Spectroscopic methodology, viscosity measurement and molecular docking. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 136, 443–450. doi:10.1016/j.saa.2014.09.056
   PubMed Web of Science ®Google Scholar
• Shi, J. H., Liu, T. T., Jiang, M., Chen, J., & Wang, Q. (2015). Characterization of interaction of calf thymus DNA with gefitinib: Spectroscopic methods and molecular docking. Journal of Photochemistry and Photobiology B: Biology, 147, 47–55. doi:10.1016/j.jphotobiol.2015.03.005
   PubMed Web of Science ®Google Scholar
• Shi, J. H., Lou, Y. Y., Zhou, K. L., & Pan, D. Q. (2018). Probing the behavior of calf thymus DNA upon binding to a carboxamide fungicide boscalid: Insights from spectroscopic and molecular docking approaches. Journal of Biomolecular Structure and Dynamics, 36(10), 2738–2745. doi:10.1080/07391102.2017.1365012
   PubMed Web of Science ®Google Scholar
• Shi, J. H., Pan, D. Q., Zhou, K. L., & Lou, Y. Y. (2019). Exploring the binding interaction between herring sperm DNA and sunitinib: Insights from spectroscopic and molecular docking approaches. Journal of Biomolecular Structure and Dynamics, 37(4), 837–845. doi:10.1080/07391102.2018.1445033
   PubMed Web of Science ®Google Scholar
• Shi, J. H., Zhou, K. L., Lou, Y. Y., & Pan, D. Q. (2018). Multi-spectiscopic and molecular docking studies on the interaction of darunavir, a HIV inhibitor with calf thymus DNA. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 193, 14–22. doi:10.1016/j.saa.2017.11.061
   PubMed Web of Science ®Google Scholar
• Shinya, K., Toshihiko, A., & Kensuke, K. (2014). Ever-advancing chronic myelold leukemia treatment. International Journal of Clinical Oncology, 19, 3–9. doi:10.1007/s10147-013-0641-7
   PubMed Web of Science ®Google Scholar
• Talpaz, M., Shah, N. P., Kantarjian, H., Donato, N., Nicoll, J., Paquette, R., … Sawyers, C. L. (2006). Dasatinib in imatinib-resistant philadelphia chromosome-positive leukemias. New England Journal of Medicine, 354(24), 2531–2541. doi:10.1056/NEJMoa055229
   PubMed Web of Science ®Google Scholar
• Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., … Zhu, X. (2001). The sequence of the human genome. Science, 291(5507), 1304–1351. doi:10.1126/science.1058040
   PubMed Web of Science ®Google Scholar
• Wang, R., & Yu, Z. (2007). Validity and reliability of Benesi-Hildebrand method. Acta Physico-Chimica Sinica, 23(9), 1353–1359. doi:10.1016/S1872-1508(07)60071-0
   Web of Science ®Google Scholar
• Wang, Y., & Zhou, A. (2007). Spectroscopic studies on the binding of methylene blue with DNA by means of cyclodextrin supramolecular systems. Journal of Photochemistry and Photobiology A: Chemistry, 190(1), 121–127. doi:10.1016/j.jphotochem.2007.03.020
   Web of Science ®Google Scholar
• Watson, J. D., & Crick, F. H. (1953). Molecular structure of nucleic acids: A structure for deoxyribose nucleic acid. Nature, 171(4356), 737–745. doi:10.1038/171737a0
   PubMed Web of Science ®Google Scholar
• Wikipedia. (2019). Dasatinib. Retrieved from https://en.wikipedia.org/wiki/Dasatinib#cite_ref-6
   Google Scholar